Pilomatricoma (pilomatrixoma)

Meet the patient

A mother brings her six-year-old to clinic over a hard lump on the cheek — there for months, slowly growing, never painful. You feel a skin-coloured nodule fixed to the overlying skin but gliding freely over the deeper tissues, and it is stony hard, like a grain of rice trapped beneath the surface, with no punctum. Stretch the skin and it goes angular; press one edge and the other dips. The diagnosis is in your fingers before the histology returns — and so is the one question that turns a single lump into a systemic work-up: "is there more than one?"[1]

One cell, one mutation, one tumour

Pilomatricoma is a tumour of the hair matrix — the cell that builds the shaft — that has lost the off-switch for the job. It is the commonest hair-follicle tumour you will meet and the commonest adnexal lesion excised in children.[1][8]

In 1999 Chan and colleagues showed these lesions carry an activating mutation in CTNNB1, the gene for beta-catenin. The mutant protein resists degradation, accumulates in the nucleus, and permanently drives the Wnt-driven matrical programme — the very pathway that normally builds a hair.[6][7]

The cell tries to make hair and fails. The proliferating basaloid (matrical) cells keratinise abnormally into anucleate eosinophilic squames — the ghost (shadow) cells — and because those dead cells are calcium-avid, dystrophic calcification follows, producing the stony hardness you feel.[6]

Etymology worth a viva mark: Malherbe coined "calcified epithelioma of sebaceous glands" in 1880 — wrong about the origin (it is hair-matrix, not sebaceous), yet the name clung for eighty years until Forbis and Helwig renamed it pilomatrixoma in 1961. "Matrix" is Latin for womb or breeding-female — the hair matrix is where the shaft is bred.[6]

The histological triad that earns the marks

Three features, in one chain, define the lesion — and the examiner wants all three named.[1]

The chain runs from edge to core: small dark basaloid cells at the periphery mature into anucleate ghost cells at the centre, calcium depositing in and among them. When a lesion ruptures, the extruded ghost cells provoke a foreign-body granuloma — the pathology behind the acutely inflamed, tender lump that brings a child in as an emergency.[2]

The classic trap: fine-needle aspiration of a pilomatricoma scatters isolated basaloid cells that look atypical and can be misread as carcinoma. Diagnose on the excision architecture — the orderly basaloid-to-ghost-cell transition — never on cytology alone.[10]

Who gets it — and the variants worth naming

Pilomatricoma is a disease of children and young adults, solitary in almost every case — and the variants only matter when they mimic something else.[8]

[8]

Two peaks in age — a dominant one in the first two decades and a smaller one in adults over fifty. Lesions favour the face, neck and upper extremities, the face alone accounting for about half.[8]

The recognised variants are mostly examiner differentials, because each mimics a commoner lesion:[2]

[2]

Three facts at the bedside — age, site, consistency

A child, a face or neck or upper-limb site, and a stony-hard nodule with no punctum — that triad makes the diagnosis before any test.[3]

The lesion is a deep-seated nodule of half a centimetre to three centimetres, skin-coloured but often carrying a faint blue-grey tint where the calcified core shines through thinned dermis. It is fixed to the overlying skin yet mobile over deeper structures — the reverse of a lump tethered to deep tissue, which is never a pilomatricoma and demands imaging.[8]

Two named signs settle the bedside diagnosis:[1]

[1]

The teeter-totter sign is the most specific: a rigid calcified pellet in a dermal pocket tilts as a unit under pressure. The tent sign is more sensitive but less specific. Either way, stony hardness with no punctum in the right patient makes a confident clinical diagnosis and spares the child an unnecessary scan.[1]

The face-off — what else is stony-hard?

"Stony-hard subcutaneous nodule" is a short list, but it hides two mimics that bite — the epidermoid cyst and, rarely, pilomatrix carcinoma.[7]

[8]

The single most discriminating bedside test is the combination of stony hardness, no punctum, and a child: epidermoid cysts — the commonest mimic — are softer and punctate, and everything else is softer, in the wrong age group, or differently surfaced.[8]

When the picture is ambiguous, dermoscopy helps. Pilomatricoma shows white and white-blue structureless areas with reddish zones — crucially not the arborising vessels of a basal cell carcinoma and not the crown vessels of sebaceous hyperplasia.[9]

Confirm it, then excise it

The diagnosis is clinical in most cases; dermoscopy and ultrasound are reserves for doubt, and histology is both confirmatory and therapeutic.[3]

For a deep or parotid-region lesion, ultrasound is the modality of choice: a thin hyperechoic rim, a hypoechoic centre, and posterior acoustic shadowing from calcification make a "target lesion" that is diagnostic — and that spares the facial nerve a blind needle.[3]

Pilomatricoma is benign but never regresses on its own, so surgical excision is the definitive treatment — there is no role for cryotherapy, laser, intralesional steroid, or any topical agent.[1]

A small, superficial, non-adherent lesion enucleates through a short incision along a relaxed skin-tension line and shells out intact; a deeper, skin-tethered, or atypical lesion needs an elliptical excision taking the overlying skin. An atypical or recurrent lesion is never enucleated — it is excised with a margin and fully submitted for histology.[10]

An acutely inflamed or ruptured lesion is settled first with a short course of an oral anti-staphylococcal antibiotic — for example flucloxacillin 250 to 500 mg four times daily for five to seven days in an adult, or 12.5 to 25 mg per kilogram four times daily in a child — and definitive excision is deferred until the inflammation subsides, to spare the child a hypertrophic facial scar.[1]

[1]

Count the lesions — the syndromes that change everything

A single pilomatricoma needs no work-up. Two or more turns a skin lump into a genetics referral — because multiplicity is a cutaneous flag for several syndromes.[4]

Roughly two to ten percent of patients have more than one lesion. Multiple, familial, or atypically sited pilomatricomas should prompt a targeted screen:[4]

[4]

The syndrome that matters most is Gardner. The triad of epidermoid cysts, osteomas and pilomatricomas can appear years or decades before the colonic polyposis declares itself — and that polyposis progresses inevitably to colorectal cancer if left untreated. A child with multiple pilomatricomas and a family history of early colon cancer must be referred for APC testing and surveillance colonoscopy.[4]

The anaesthetic trap — myotonic dystrophy. Patients with DM1 are exquisitely sensitive to anaesthetic agents: suxamethonium can precipitate sustained myotonic rigidity, and postoperative respiratory depression is a real risk. Any patient with known or suspected myotonic dystrophy booked for excision must have a dedicated anaesthetic review first.[5]

When stony-hard turns sinister — pilomatrix carcinoma

Pilomatrix carcinoma is the rare — under one percent — malignant counterpart, and three features should send you for the biopsy tray: rapid growth, a lesion over 3 cm, and recurrence or ulceration.[10]

Histologically, carcinoma shows atypia, frequent mitoses, deep invasion and an infiltrative pattern — the opposite of the orderly basaloid-to-ghost-cell maturation of a benign lesion. Manage with wide local excision and long-term follow-up; metastasis can occur.[10]

Consultant confession: the temptation with a tiny, classic cheek lesion in a calm child is to watch it indefinitely. Do not promise it will go away — it never does. Time the excision for convenience (one general anaesthetic, batch any siblings), but plan the incision along a relaxed skin-tension line — a 2 mm scar beats a 2 cm one.[8]

The mantra: stony hard, no punctum, child's cheek — pilomatricoma. Excise it, send it, and count the lesions.[1]

Ward-round test

A seven-year-old has a 1 cm rock-hard nodule on the cheek, fixed to skin, mobile over deeper tissues, with no punctum. Diagnosis and first step?

Pilomatricoma until proved otherwise — the triad of age, site and stony hardness makes the clinical diagnosis. The first step is surgical excision (enucleation for a small superficial lesion), with the specimen sent for histology to confirm the diagnosis and exclude pilomatrix carcinoma.[1]

The same child has three similar nodules and a father with colon cancer in his thirties. What do you do beyond the skin?

Screen for Gardner syndrome (familial adenomatous polyposis): take a targeted family history, examine for osteomas and ocular fundus pigmentation (CHRPE), and refer for APC gene testing and surveillance colonoscopy. The skin lesion can predate colon cancer by years, so early surveillance is life-saving.[4]

A 45-year-old has a rapidly enlarging 4 cm ulcerated mass on the scalp where a cyst was removed two years ago. What is the concern?

Pilomatrix carcinoma — rapid growth, a size over 3 cm, recurrence and ulceration are the red flags. Arrange wide local excision with expert dermatopathology and plan long-term follow-up; metastasis can occur.[10]

Histology of a cheek nodule reports ghost cells and calcification. Name the cell of origin and the driver mutation.

Hair-matrix (matrical) cells, driven by an activating CTNNB1 (beta-catenin) mutation that constitutively switches on Wnt-driven matrical differentiation — the landmark finding of Chan and colleagues, 1999.[6]

References

1. [1]Jones CD, et al. Pilomatrixoma: A Comprehensive Review of the Literature. Am J Dermatopathol, 2018.PMID 30119102
2. [2]Sung KY, et al. Pseudocystic pilomatricoma: A new variant and review of the literature. Australas J Dermatol, 2021.PMID 32700760
3. [3]Dang J, et al. Pilomatricoma in the right parotid region: A case report and review of the literature. Asian J Surg, 2023.PMID 36535873
4. [4]Saponaro G, et al. Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome. Dermatopathology (Basel), 2025.PMID 40843798
5. [5]Adam MP, et al. Myotonic Dystrophy Type 1. GeneReviews, 1993.PMID 20301344
6. [6]Chan EF, et al. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet, 1999.PMID 10192393
7. [7]Chan EF Pilomatricomas contain activating mutations in beta-catenin. J Am Acad Dermatol, 2000.PMID 11004631
8. [8]Hassan SF, et al. Characterizing pilomatricomas in children: a single institution experience. J Pediatr Surg, 2013.PMID 23895971
9. [9]Zaballos P, et al. Dermoscopic findings of pilomatricomas. Dermatology, 2008.PMID 18663304
10. [10]Hardisson D, et al. Pilomatrix carcinoma: a clinicopathologic study of six cases and review of the literature. Am J Dermatopathol, 2001.PMID 11801770